02138.HK
EC Healthcare
HKSE · Consumer Defensive · Household & Personal Products · HK
HKD 0.44
+6.10%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 7.9B | 3.8B | 4.1B | 4.2B | 3.9B |
| Cost of Revenue | 3.7B | 3.2B | 798.0M | 666.1M | 553.0M |
| Gross Profit | 4.2B | 600.3M | 3.3B | 3.5B | 3.3B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 888.0M | — | 432.4M | 426.4M | 405.4M |
| General & Admin Expense | 383.6M | — | 254.9M | 219.2M | 232.6M |
| Selling & Marketing Expense | 260.6M | — | 177.5M | 207.2M | 172.7M |
| Other Expenses | 2.9B | 565.7M | 2.8B | 2.9B | (36.4M) |
| Total Operating Expenses | 3.8B | 565.7M | 3.2B | 3.4B | 3.1B |
| Cost and Expenses | 7.5B | 3.7B | 4.0B | 4.1B | 3.6B |
| Operating Income (EBIT) | 390.9M | 34.6M | 94.9M | 109.0M | 218.9M |
| Non-Operating | |||||
| Interest Income | 33.4M | 16.0M | 17.4M | 15.6M | 4.5M |
| Interest Expense | 156.1M | 71.7M | 89.4M | 100.8M | 63.6M |
| Net Interest Income | (129.5M) | (55.6M) | (72.0M) | (85.3M) | (59.1M) |
| Other Non-Op Income/Expense | (902.2M) | (444.7M) | (196.1M) | (92.2M) | (55.4M) |
| Non-Operating Income (excl Interest) | 365.9M | — | 106.6M | (8.7M) | (8.3M) |
| EBT (Pre-Tax Income) | (511.3M) | (410.2M) | (101.1M) | 16.9M | 136.2M |
| Income Tax Expense | 24.6M | 2.7M | 10.8M | 1.2M | 29.2M |
| Bottom Line | |||||
| Net Income | (569.9M) | (402.7M) | (167.2M) | (18.9M) | 69.7M |
| Earnings from Cont. Ops | (524.8M) | (412.9M) | (111.9M) | 15.7M | 107.0M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (569.9M) | (402.7M) | (167.2M) | (18.9M) | 69.7M |
| Per Share | |||||
| Basic EPS | (HK$0.48) | (HK$0.34) | (HK$0.14) | (HK$0.02) | HK$0.06 |
| Diluted EPS | (HK$0.48) | (HK$0.34) | (HK$0.14) | (HK$0.02) | HK$0.06 |
| Revenue Per Share | HK$6.67 | HK$3.18 | HK$3.49 | HK$3.55 | HK$3.28 |
| Shares | |||||
| Basic Shares Outstanding | 1.2B | 1.2B | 1.2B | 1.2B | 1.2B |
| Diluted Shares Outstanding | 1.2B | 1.2B | 1.2B | 1.2B | 1.2B |
| Profitability Metrics | |||||
| EBITDA | 1.0B | 546.8M | 619.3M | 743.3M | 786.6M |
| D&A | 1.0B | 512.2M | 631.0M | 625.5M | 586.7M |
| EBIT | 25.1M | 34.6M | (11.7M) | 117.7M | 199.8M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026